Xie, Youmei
Meeker, Rick B.
Massa, Stephen M.
Longo, Frank M.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01 NS083164)
Alzheimer's Drug Discovery Foundation
Alzheimer's Association
Eastern Chapter of the North Carolina Alzheimer’s Association
Article History
Received: 28 September 2018
Accepted: 8 February 2019
First Online: 27 March 2019
Competing Interests
: Drs Longo and Massa are listed as inventors on patents relating to a compound in this report that is assigned to the University of North Carolina, University of California, San Francisco and the Dept. of Veterans Affairs. Drs Massa and Longo are entitled to royalties distributed by UC and the VA per their standard agreements. Dr. Longo is a principal of, and has financial interest in PharmatrophiX, a company focused on the development of small molecule ligands for neurotrophin receptors that has licensed several of these patents.